Variant report

Variant	nsv892078
Chromosome Location	chr9:2668085-2705874
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:2677676..2680039-chr9:2680845..2683577,2	K562	blood:
2	chr9:2677676..2680039-chr9:2680845..2683577,2	K562	blood:
3	chr9:2697672..2699456-chr9:2700934..2702755,2	MCF-7	breast:
4	chr9:2682099..2684421-chr9:2688632..2690767,2	MCF-7	breast:
5	chr9:2695521..2698232-chr9:3222806..3225730,2	K562	blood:
6	chr9:2697672..2699456-chr9:2700934..2702755,2	MCF-7	breast:
7	chr9:2672525..2674889-chr9:2677080..2679041,2	MCF-7	breast:
8	chr9:2672525..2674889-chr9:2677080..2679041,2	MCF-7	breast:
9	chr9:2682099..2684421-chr9:2688632..2690767,2	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KIAA0020-4	chr9:2704045-2704737	NONHSAT130005
2	lnc-KIAA0020-4	chr9:2697878-2698075	NONHSAT130005
3	lnc-KIAA0020-4	chr9:2700367-2700587	NONHSAT130005
4	lnc-KIAA0020-4	chr9:2683510-2684133	NONHSAT130005

No data

Extended variants
information (count: 1982 )
Associated
traits (count: 100 )

Variant overlapped rSNPs/rCNVs (count:1982 , 50 per page) page: 1 2 3 4 5 6 7 ... 40

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1470943	chr9:2668085-2668086	Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
2	rs536978313	chr9:2668098-2668099	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs149451209	chr9:2668134-2668135	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs117937724	chr9:2668152-2668153	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs143893363	chr9:2668158-2668159	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs200439233	chr9:2668182-2668183	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs4741756	chr9:2668187-2668188	Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
8	rs148794308	chr9:2668222-2668223	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs528050413	chr9:2668224-2668225	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs551083783	chr9:2668259-2668260	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs541640512	chr9:2668286-2668287	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs12156533	chr9:2668292-2668293	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs12343708	chr9:2668297-2668298	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs143949804	chr9:2668302-2668303	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs146833432	chr9:2668310-2668311	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs117615376	chr9:2668364-2668365	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs552159992	chr9:2668369-2668370	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs139706331	chr9:2668376-2668377	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs528221170	chr9:2668450-2668451	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs374481680	chr9:2668472-2668473	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs116610665	chr9:2668508-2668509	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs567949924	chr9:2668615-2668616	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs370929928	chr9:2668616-2668617	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs536867597	chr9:2668739-2668740	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs550729720	chr9:2668763-2668764	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs550411504	chr9:2668785-2668786	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs570731594	chr9:2668786-2668787	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs188014947	chr9:2668885-2668886	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs375349862	chr9:2668900-2668901	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs558956001	chr9:2668918-2668919	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs572427064	chr9:2668922-2668923	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs144258086	chr9:2668937-2668938	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs191377387	chr9:2668997-2668998	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs536860179	chr9:2668998-2668999	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs182134707	chr9:2669004-2669005	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs577510459	chr9:2669009-2669010	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs545481549	chr9:2669023-2669024	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs559331137	chr9:2669033-2669034	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs186869170	chr9:2669034-2669035	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs547850874	chr9:2669044-2669045	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs561448452	chr9:2669109-2669110	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs113595275	chr9:2669120-2669121	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs141006665	chr9:2669132-2669133	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs573447339	chr9:2669166-2669167	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs539749084	chr9:2669214-2669215	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs552271536	chr9:2669227-2669228	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs566044166	chr9:2669343-2669344	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs116899690	chr9:2669376-2669377	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs555054800	chr9:2669429-2669430	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs192526747	chr9:2669456-2669457	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:100)

Disease	PMID	Source
Gastric cancer	16715143	CNVD
Glioblastoma multiforme	22286061	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Disorders of sex development	21048976	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Myelofibrosis	22110671	CNVD
Developmental delay	21373258	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hepatocellular carcinoma	18803288	CNVD
Schizophrenia	23813976	CNVD
Ovarian cancer	22355333	CNVD
Schizophrenia	20967226	CNVD

Chromatin state (count:199 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:2641400-2668400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr9:2656000-2677800	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr9:2665000-2670400	Weak transcription	Psoas Muscle	Psoas
4	chr9:2669000-2669400	Enhancers	Fetal Brain Female	brain
5	chr9:2670400-2670600	Enhancers	Psoas Muscle	Psoas
6	chr9:2673400-2675000	Enhancers	Stomach Mucosa	stomach
7	chr9:2673800-2674000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr9:2673800-2674200	Enhancers	Ovary	ovary
9	chr9:2674000-2674400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
10	chr9:2674000-2674400	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
11	chr9:2674400-2675000	Weak transcription	Ovary	ovary
12	chr9:2674400-2677800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr9:2674400-2678200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr9:2675000-2675800	Weak transcription	Stomach Mucosa	stomach
15	chr9:2675600-2676800	Enhancers	Breast Myoepithelial Primary Cells	Breast
16	chr9:2675800-2676200	Enhancers	Psoas Muscle	Psoas
17	chr9:2675800-2676600	Enhancers	Skeletal Muscle Female	skeletal muscle
18	chr9:2675800-2678600	Enhancers	Stomach Mucosa	stomach
19	chr9:2676000-2676200	Enhancers	Ovary	ovary
20	chr9:2676000-2676800	Enhancers	Fetal Muscle Leg	muscle
21	chr9:2676200-2678200	Weak transcription	Psoas Muscle	Psoas
22	chr9:2676400-2676600	Enhancers	ES-I3 Cell Line	embryonic stem cell
23	chr9:2676400-2676600	Enhancers	HSMM	muscle
24	chr9:2676400-2677200	Enhancers	HepG2	liver
25	chr9:2676600-2676800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr9:2676600-2676800	Enhancers	A549	lung
27	chr9:2676600-2677000	Enhancers	HUVEC	blood vessel
28	chr9:2676600-2677800	Weak transcription	Skeletal Muscle Female	skeletal muscle
29	chr9:2676800-2677800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
30	chr9:2677000-2677600	Weak transcription	A549	lung
31	chr9:2677200-2677800	Weak transcription	HepG2	liver
32	chr9:2677200-2678200	Enhancers	iPS-15b Cell Line	embryonic stem cell
33	chr9:2677400-2678400	Enhancers	HUES64 Cell Line	embryonic stem cell
34	chr9:2677400-2678400	Enhancers	iPS-18 Cell Line	embryonic stem cell
35	chr9:2677400-2678800	Enhancers	HUES48 Cell Line	embryonic stem cell
36	chr9:2677600-2677800	Enhancers	A549	lung
37	chr9:2677600-2678400	Enhancers	iPS-20b Cell Line	embryonic stem cell
38	chr9:2677600-2678600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
39	chr9:2677600-2679400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
40	chr9:2677800-2678200	Enhancers	HUES6 Cell Line	embryonic stem cell
41	chr9:2677800-2678400	Enhancers	H9 Cell Line	embryonic stem cell
42	chr9:2677800-2678400	Enhancers	HepG2	liver
43	chr9:2677800-2678600	Enhancers	ES-I3 Cell Line	embryonic stem cell
44	chr9:2677800-2678600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
45	chr9:2677800-2678600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr9:2677800-2678600	Weak transcription	A549	lung
47	chr9:2677800-2678800	Enhancers	Adipose Nuclei	Adipose
48	chr9:2677800-2679400	Enhancers	Skeletal Muscle Female	skeletal muscle
49	chr9:2677800-2679600	Enhancers	Skeletal Muscle Male	skeletal muscle
50	chr9:2678000-2678600	Enhancers	Aorta	Aorta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links